Description
Ibudilast research compound
Ibudilast is a non-selective phosphodiesterase inhibitor that also inhibits macrophage migration inhibitory factor (MIF).
Product details
| Compound | Ibudilast (MN-166) |
|---|---|
| Class | Phosphodiesterase inhibitor |
| Form | Powder; Tablets; Liquid |
| Strength | 1g; 40mg per tablet/27ct/1080mg; 40mg per tablet/54ct/2160mg; 30ml/33mg per ml/1000mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What research has examined
- PDE inhibition research.
- Glial cell research.
- Clinical research: neurology trials.
Research interest does not establish a proven effect in humans.
Regulatory status
Ibudilast is licensed in Japan but not by the FDA or EMA. Supplied as a research chemical only.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from moisture and light.
Related research products
Bromantane · Agomelatine · CDP Choline (Citicoline) · All nootropic powders
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.